| Ytd | 27.30% | |
| 1y | 102.30% |
| Open | 14.55 | Prev Close | 14.59 | Low | 14.54 | High | 15.20 | Mkt Cap | 1.95B |
| Vol | 3.23M | Avg Vol | 2.57M | EPS | -0.77 | P/E | N/A | Forward P/E | 41.06 |
| Beta | 1.81 | Short Ratio | 6.00 | Inst. Own | 108.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 10.16 | 200-d Avg | 10.21 | 1yr Est | 15.06 |
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of Carolyn Starrett to its
In addition, NeoGenomics granted the initial purchasers of the notes an option to purchase, for sett
solutions that enable precision medicine, announced today that it has commenced a private offering o